Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy

Area of Science:

• Oncology
• Immunology
• Genetics

Background:

• Spontaneous T cell responses in cancer patients recognize specific tumor antigens.
• Most tumor antigens are tumor-specific, arising from genetic mutations.
• Identifying these antigens is key to understanding anti-tumor immunity.

Purpose of the Study:

• To describe the characteristics of tumor antigens recognized by spontaneous T cell responses.
• To explain the genetic basis of tumor antigen specificity.
• To discuss the safety implications of targeting tumor antigens in immunotherapy.

Main Methods:

• Review of existing literature on tumor antigens and T cell responses.
• Analysis of genetic underpinnings of tumor antigen presentation.
• Evaluation of immunotherapy strategies targeting tumor antigens.

Main Results:

• Characterization of tumor antigens eliciting spontaneous T cell responses.
• Explanation of the genetic basis for tumor specificity in most, but not all, antigens.
• Identification of safety concerns related to cross-reactive T cell responses.

Conclusions:

• Targeting tumor-specific antigens can lead to desired anti-tumor immunity or unintended cross-reactivity.
• Safety concerns are heightened when targeting antigens lacking spontaneous T cell recognition.
• Further research is needed to optimize immunotherapy strategies based on antigen characteristics.